To access AIS Channel content, please allow all cookies. Please click here to configure your preferences.
Sleeve gastrectomy was initially a bariatric procedure with limited indications, such as patients with high anesthesia risk, with BMI > 50 Kg/m2, hostile surgical fields, e.g. a bridge to transplant surgery or cases of inflammatory bowel disease. This scenario changed quickly due to its acceptance by the surgical community, mainly because it is supposed to be less demanding and quicker to perform.
Long-term results showed good outcomes in terms of weight loss and resolution of comorbidities and it is currently a popular operation. However, complications such as gastro-esophageal reflux disease remain an issue, and the percentage of patients who require revision is increasing.
In this lecture, Pim Van Rutte from Eindhoven Hospital in the Netherlands explains the pathophysiological mechanisms involved in this phenomenon.